BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miller MC, Zheng Y, Suylen D, Ippel H, Cañada FJ, Berbís MA, Jiménez-Barbero J, Tai G, Gabius HJ, Mayo KH. Targeting the CRD F-face of Human Galectin-3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative. ChemMedChem 2021;16:713-23. [PMID: 33156953 DOI: 10.1002/cmdc.202000742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Raics M, Balogh ÁK, Kishor C, Timári I, Medrano FJ, Romero A, Go RM, Blanchard H, Szilágyi L, E Kövér K, Fehér K. Investigation of the Molecular Details of the Interactions of Selenoglycosides and Human Galectin-3. Int J Mol Sci 2022;23:2494. [PMID: 35269646 DOI: 10.3390/ijms23052494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sanjurjo L, Schulkens IA, Touarin P, Heusschen R, Aanhane E, Castricum KCM, De Gruijl TD, Nilsson UJ, Leffler H, Griffioen AW, Elantak L, Koenen RR, Thijssen VLJL. Chemokines modulate glycan binding and the immunoregulatory activity of galectins. Commun Biol 2021;4:1415. [PMID: 34931005 DOI: 10.1038/s42003-021-02922-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Pfeifer L, Baumann A, Petersen LM, Höger B, Beitz E, Classen B. Degraded Arabinogalactans and Their Binding Properties to Cancer-Associated Human Galectins. Int J Mol Sci 2021;22:4058. [PMID: 33920014 DOI: 10.3390/ijms22084058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]